DNA vaccine against malaria: A long way to go

Critical Reviews in Biochemistry and Molecular Biology

Volumn 37, Issue 1, 2002, Pages 29-54

  Tuteja, Renu ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; DNA VACCINE; MALARIA VACCINE;

CELLULAR IMMUNITY; DRUG EFFICACY; DRUG MECHANISM; GENETIC CODE; IMMUNE RESPONSE; IMMUNOTHERAPY; INFECTION PREVENTION; LIFE CYCLE; MALARIA; NONHUMAN; PLASMODIUM; PRIORITY JOURNAL; REVIEW; VACCINATION;

ANIMALS; ANTIGENS, PROTOZOAN; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; LIVER; MALARIA; MALARIA VACCINES; MEROZOITE SURFACE PROTEIN 1; PLASMODIUM; PROTOZOAN PROTEINS; VACCINES, DNA;

PROTOZOA;

EID: 0036126593     PISSN: 10409238     EISSN: None     Source Type: Journal    
DOI: 10.1080/10409230290771447     Document Type: Review

References (59)

1. Enhancement of the immune response in rabbits to a malaria DNA vaccine by immunization with a needle-free jet device
2. Malaria vaccines
3. Comparative immunization study using RNA and DNA construct encoding a part of the Plasmodium falciparum antigen Pf332
4. The evolution of DNA vaccines
5. Protection of mice against Plasmodium yoelii sporozoite challenge with P. yoelii merozoite surface protein 1 DNA vaccines
6. Immune responses induced by gene gun or intramuscular injection of DNA vaccines that express immunogenic regions of the serine repeat antigen from Plasmodium falciparum
7. Genomic tools for gene and protein discovery in malaria: Toward new vaccines
8. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria
9. Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3
10. Direct gene transfer into skeletal muscle in vivo: Factors affecting efficiency of transfer and stability of expression
11. Antigenic properties of the merozoite surface protein 1 gene of Plasmodium vivax
12. Thrombospondin related adhesive protein (TRAP), a potential malaria vaccine candidate
13. DNA vaccination as an approach to malaria control: Current status and strategies
14. DNA-based vaccines against malaria: Status and promise of the Multi-Stage Malaria DNA Vaccine Operation
15. Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity
16. DNA vaccines: Protective immunization by parenteral, mucosal and gene gun inoculation
17. Malaria DNA vaccines in Aotus monkeys
18. Characterization of antibody responses to a Plasmodium falciparum blood-stage antigen induced by a DNA prime/protein boost immunization protocol
19. DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: Immunogenicity in mice
20. In vitro expression and in vivo immunoge-nicity of Plasmodium falciparum preerythrocytic stage DNA vaccines
21. Toward clinical trials of DNA vaccines against malaria
22. Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine
23. Biology of malarial liver stages: Implications for vaccine design
24. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen
25. Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite
26. Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers
27. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasite
28. Immunization of mice with DNA-based Pfs25 elicits potent malaria transmission-blocking antibodies
29. Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA
30. Plasmid DNA malaria vaccine: Tissue distribution and safety studies in mice and rabbits
31. Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine
32. Current status of malaria and potential for control
33. Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular immunity to viruses
34. Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in Rhesus macaques
35. Construction and immunogenicity of DNA vaccine plasmids encoding four Plasmodium vivax candidate vaccine antigens
36. DNA immunization with Plasmodium falciparum serine repeat antigen: Regulation of humoral immune response by coinoculation of cytokine expression plasmid
37. Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice
38. DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge
39. Removal of the circumsporozoite protein (CSP) glycosylphosphatidyl-inositol signal sequence from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improves protection against malaria infection
40. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
41. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein
42. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine
43. Improving protective immunity induced by DNA-based immunization: Priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus
44. Induction of biologically active antibodies in mice, rabbits, and monkeys by Plasmodium falciparum EBA-175 region II DNA vaccine
45. Expression library immunization protects mice against a challenge with virulent rodent malaria
46. Searching for a parasites weak spot
47. Vaccination against malaria: Targets, strategies and potentiation of immunity to blood stage parasites
48. DNA vaccines: A ray of hope
49. Augmentation of immune responses to hepatitis E virus ORF2 DNA vaccination by codelivery of cytokine genes
50. Gene transfer in regenerating muscle
51. Gene inoculation generates immune responses against human immunodeficincy virus type I
52. Differences in epitope recognition, isotype and titer of antisera to Plasmodium falciparum merozoite surface protein 4 raised by different modes of DNA or protein immunization
53. Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids
54. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine
55. + type 1 responses in humans by a malaria DNA vaccine
56. A plasmid encoding murine granulocyte-macrophage colony stimulating factor increases protection conferred by a malaria DNA vaccine
57. Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite protein
58. Genetic immunization of BALB/c mice with a plasmid bearing the gene coding for a hybrid merozoite surface protein 1-hepatitis B virus surface protein fusion protects mice against lethal Plasmodium chabaudi chabaudi PC1 infection
59. Direct immunization of malaria DNA vaccine into the liver protects against lethal challenge of Plasmodium berghei sporozoite